| 12.04 15:32 | dpa-AFX: Illumina's Divestment Plan For Grail Receives Approval From European Commission |
| 12.04 15:04 | dpa-AFX: *ILLUMINA'S DIVESTMENT PLAN FOR GRAIL RECEIVES EUROPEAN COMMISSION APPROVAL |
| 09.04 22:29 | dpa-AFX: Illumina Appoints Ankur Dhingra CFO, Reaffirms Q1 And FY24 Outlook |
| 09.04 22:10 | dpa-AFX: *ILLUMINA APPOINTS JAKOB WEDEL AS CHIEF STRATEGY AND CORPORATE DEVELOPMENT OFFICER |
| 09.04 22:10 | dpa-AFX: *ILLUMINA APPOINTS JAKOB WEDEL AS CHIEF STRATEGY AND CORPORATE DEVELOPMENT OFFICER |
| 09.04 22:09 | dpa-AFX: *ILLUMINA APPOINTS ANKUR DHINGRA AS CFO |
| 08.02 22:13 | dpa-AFX: *ILLUMINA Q4 LOSS/SHARE $1.11 VS. LOSS $0.89 YEAR AGO |
| 08.02 22:13 | dpa-AFX: *ILLUMINA Q4 REVENUES $1.12 BLN VS. $1.08 BLN LAST YEAR |
| 08.02 22:13 | dpa-AFX: *ILLUMINA Q4 NET LOSS $176 MLN VS. LOSS $140 MLN PRIOR YEAR |
| 08.02 22:12 | dpa-AFX: Illumina Inc. Q4 Earnings Summary |
| 09.01 17:00 | dpa-AFX: Illumina To Present At J.P. Morgan Healthcare Conference; Webcast At 12:00 PM ET |
| 09.01 16:53 | dpa-AFX: Illumina Expects Q4 Revenue Better Than View; Stock Up |
| 09.01 15:04 | dpa-AFX: *ILLUMINA Q4 REVENUE ABOUT $1.115 BLN, UP 3% FROM LAST YEAR |
| 05.01 16:28 | dpa-AFX: Illumina Collaborates With Janssen To Develop MRD Cancer Test |
| 05.01 15:22 | dpa-AFX: *ILLUMINA EXPANDS COLLABORATION WITH JANSSEN RESEARCH & DEVELOPMENT TO ADVANCE MOLECULAR RESIDUAL DISEASE CANCER TEST |
| 02.01 05:15 | dpa-AFX: WDH/Die Tops und Flops im Nasdaq 100 im Jahr 2023 |
| 29.12 22:34 | dpa-AFX: Die Tops und Flops im Nasdaq 100 im Jahr 2023 |
| 29.12 22:34 | Die Tops und Flops im Nasdaq 100 im Jahr 2023 |
| 29.12 22:29 | dpa-AFX: Die Tops und Flops im Nasdaq 100 im Jahr 2023 |
| 18.12 15:41 | MÄRKTE USA/Gut behauptet - Dow-Jones mit neuem Rekordhoch |
|
|
